Ms. Shadan joined Rotation Medical in 2013 as President & CEO with over 30 years of experience as a business leader in a variety of organizations. Rotation Medical, Inc. was acquired by Smith & Nephew plc in December 2017. Prior to joining Rotation Medical Martha was the President of the Trauma Division at Zimmer where she managed the P&L for the global business. Martha served at Covidien as VP/General Manager of Vascular Therapies and VP/General Manager BioSurgery and Sports Surgery. Other companies that have benefited from Martha Shadan’s experience and leadership include Bristol Myers Squibb Co. and Merck Millipore. Martha holds a M.B.A from Northeastern University, M.S. Biology, Michigan State University, and B.S. Biology, University of New Hampshire.
Ms. Martha Shadan is the Executive Chairwoman of the Board of Directors for a medical device start-up, IlluminOss. Ms. Shadan has served on the AdvaMed Board of Directors since 2017, the AdvaMed Accel Board of Directors since 2015. She was also a founding member of the Leadership Circle for AdvaMed’s Women’s Executive Network (WEN).